Wikidata

(Q63393209)

English

Safety Study of Stemchymal® in Acute Liver Failure

clinical trial

In more languages

Statements

short name
ALF (English)
0 references
title
The Safety Study of Stemchymal® (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I Trial (English)
0 references
country
Taiwan
0 references
start time
1 October 2018
0 references
end time
29 February 2020
0 references
number of participants
20
0 references
minimum age
20 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63393209&oldid=1857185159"